SGH
WST icon

Sivik Global Healthcare’s West Pharmaceutical WST Stock Holding History

Sivik Global Healthcare’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$3.94M – 55
2025
Q3 		$3.94M Hold
15,000
– – 1.14% 36
2025
Q2 		$3.28M Buy
15,000
+2,500
+20% +$534K 0.89% 36
2025
Q1 		$2.8M Buy
+12,500
New +$3.45M 1.51% 28
2024
Q4 		– Sell
-17,000
Closed -$5.1M – 47
2024
Q3 		$5.1M Buy
17,000
+4,000
+31% +$1.22M 2.16% 21
2024
Q2 		$4.28M Buy
13,000
+3,000
+30% +$1.06M 1.54% 28
2024
Q1 		$3.96M Buy
+10,000
New +$3.7M 0.93% 33
2022
Q1 		– Sell
-7,500
Closed -$3.52M – 59
2021
Q4 		$3.52M Buy
+7,500
New +$3.23M 1.51% 32

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sivik Global Healthcare's WST Position: Q4 2025 in Review

Sivik Global Healthcare sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 15,000 shares — an estimated $3.94M sold.

Sivik Global Healthcare first reported a position in WST in Q4 2021 and held it in 7 quarters. The position peaked at $5.1M in Q3 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Sivik Global Healthcare reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Sivik Global Healthcare sold 15,000 West Pharmaceutical shares in Q4 2025, an estimated $3.94M.
  • Sivik Global Healthcare first reported a position in West Pharmaceutical in Q4 2021 and held it in 7 quarters.
  • Sivik Global Healthcare's West Pharmaceutical position peaked at $5.1M in Q3 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.